Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …

Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

We employed scRNA sequencing to extensively characterize the cellular landscape of
human liver from development to disease. Analysis of∼ 212,000 cells representing human …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …

Background Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Many individuals have risk factors associated with NAFLD, but the …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …

1. BACKGROUND Cynthia Mulrow's important paper calling for literature reviews to be
undertaken more systematically (and hence be more informative and reliable) is now 30 …

NAFLD is one of the most important causes of liver disease worldwide and will probably
emerge as the leading cause of end-stage liver disease in the coming decades, with the …

Background & Aims The development of non-invasive liver fibrosis tests may enable earlier
identification of patients with non-alcoholic fatty liver disease (NAFLD) requiring referral to …